Third dose of COVID-19 vaccine effective for immunocompromised patients with blood cancers - Healio

A third dose of the mRNA-1273 vaccine for COVID-19 significantly improved SARS-CoV-2 antibody concentrations among patients with hematologic malignancies who previously received two doses, results of a prospective study showed. In the study, published in JAMA…

Key takeaways:

• Three mRNA vaccine doses resulted in significantly higher concentrations of anti-spike antibodies similar to those seen in healthy adults who received two standard doses.
… [+4571 chars]
full article...